Securities Registration (section 12(b)) (8-a12b)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

DELMAR PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

Nevada		99-0360497
(State of incorporation or organization)		(IRS Employer Identification No.)

 

Suite 720-999 West Broadway

Vancouver, British Columbia

Canada V5Z 1K5

(Address of principal executive offices) (Zip Code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class to be registered:  Common Stock, par value $0.001 per share

Name of each exchange on which each class is to be registered:  The NASDAQ Stock Market LLC

 

If this Form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. ☒

If this Form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.  o

 

Securities Act registration statement file number to which this form relates: _______ (if applicable)

 

Securities to be registered pursuant to Section 12(g) of the Act: None.

 

 

Item 1.    Description of Registrant's Securities to be Registered.

 

The description of the common stock of DelMar Pharmaceuticals, Inc. (the “Registrant”), as included under the caption “Description of Securities” in the prospectus forming a part of the Post-Effective Amendment No. 3 to Registration Statement on Form S-1 (Registration No. 333-189337) (the “Registration Statement”), filed under the Securities Act of 1933, as amended (the “Securities Act”), is incorporated by reference herein. In addition, any description of such securities contained in a form of prospectus relating to the Registration Statement subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act shall be deemed to be incorporated by reference herein.

 

Item 2.    Exhibits.

 

Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

	DELMAR PHARMACEUTICALS, INC.
Date:  July 7, 2016	By:	/s/ Jeffrey Bacha
		Name: Jeffrey Bacha
		Title:   Chief Executive Officer